Cal-Maine Foods Inc: Form 10-Q for the period ended Mar 2, 2024
Filed with the SEC on Apr 2, 2024 and accepted by EDGAR at Apr 2, 2024, 20:21 ET.
Management's discussion and analysis
As filed, 44,087 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
The following should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results
of Operations included in Part II Item 7 of the Company’s Annual Report on Form 10-K for its fiscal year ended June 3, 2023
(the “2023 Annual Report”), and the accompanying financial statements and notes included in Part II Item 8 of the 2023 Annual
Report and in
Part I Item 1
of this Quarterly Report on Form 10-Q (“Quarterly Report”).
This report contains numerous forward-looking statements within the meaning of Section 27A of the Securities Act of 1933
(the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”) relating to our shell egg
and egg products business, including estimated future production data, expected construction schedules, projected construction
costs, potential future supply of and demand for our products, potential future corn and soybean price trends, potential future
impact on our business of the recent resurgence in United States (“U.S.”) commercial table egg layer flocks of the highly
pathogenic avian influenza (“HPAI”) outbreak, potential future impact on our business of inflation and changing interest rates,
potential future impact on our business of new legislation, rules or policies, potential outcomes of legal proceedings , including
loss contingency accruals and factors that may result in changes in the amounts recorded, and other projected operating data,
including anticipated results of operations and financial condition. Such forward-looking statements are identified by the use of
words such as “believes,” “intends,” “expects,” “hopes,” “may,” “should,” “plans,” “projected,” “contemplates,” “anticipates,”
or similar words. Actual outcomes or results could differ materially from those projected in the forward-looking statements.
The forward-looking statements are based on management’s current intent, belief, expectations, estimates, and projections
regarding the Company and its industry. These statements are not guarantees of future performance and involve risks,
uncertainties, assumptions, and other factors that are difficult to predict and may be beyond our control. The factors that could
cause actual results to differ materially from those projected in the forward-looking statements include, among others, (i) the
risk factors set forth in Part I Item 1A of the 2023 Annual Report, the risk factors (if any) set forth in Part II Item 1A Risk
Factors and elsewhere in this report as well as those included in other reports we file from time to time with the Securities and
Exchange Commission (the “SEC”) (including our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K), (ii) the
risks and hazards inherent in the shell egg business (including disease, pests, weather conditions, and potential for product
recall), including but not limited to the current outbreak of HPAI affecting poultry in the U.S., Canada and other countries that
was first detected in commercial flocks in the U.S. in February 2022 and that first impacted our flock in December 2023, (iii)
changes in the demand for and market prices of shell eggs and feed costs, (iv) our ability to predict and meet demand for cage-
free and other specialty eggs, (v) risks, changes, or obligations that could result from our future acquisition of new flocks or
businesses and risks or changes that may cause conditions to completing a pending acquisition not to be met, (vi) risks relating
to increased costs and higher and potentially further increases in, inflation and interest rates, (vii) our ability to retain existing
customers, acquire new customers and grow our product mix, (viii) adverse results in pending litigation matters, and (ix) global
instability, including as a result of the war in Ukraine, the Israel-Hamas conflict and attacks on shipping in the Red Sea.
Readers are cautioned not to place undue reliance on forward-looking statements because, while we believe the assumptions on
which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements
will prove to be accurate. Further, forward-looking statements included herein are only made as of the respective dates thereof,
or if no date is stated, as of the date hereof. Except as otherwise required by law, we disclaim any intent or obligation to update
publicly these forward-looking statements, whether because of new information, future events, or otherwise.
GENERAL
Cal-Maine Foods, Inc. (the “Company,” “we,” “us,” “our”) is primarily engaged in the production, grading, packaging,
marketing and distribution of fresh shell eggs. Our operations are fully integrated and we have one operating and reportable
segment. We are the largest producer and distributor of fresh shell eggs in the U.S. Our total flock of approximately 42.2
million layers and 10.9 million pullets and breeders is the largest in the U.S. We sell most of our shell eggs to a diverse group
of customers, including national and regional grocery store chains, club stores, companies servicing independent supermarkets
in the U.S., food service distributors, and egg product consumers located primarily in states across the southwestern,
southeastern, mid-western and mid-Atlantic regions of the U.S.
Our operating results are materially impacted by market prices for eggs and feed grains (corn and soybean meal), which are
highly volatile, independent of each other, and out of our control. Generally, higher market prices for eggs have a positive
impact on our financial results while higher market prices for feed grains have a negative impact on our financial results.
Although we use a variety of pricing mechanisms in pricing agreements with our customers, we sell most of our conventional
shell eggs based on formulas that consider, in varying ways, independently quoted regional wholesale market prices for shell
eggs or formulas related to our costs of production which include the cost of corn and soybean meal. We do not sell eggs
directly to consumers or set the prices at which eggs are sold to consumers.
Retail sales of shell eggs historically have been highest during the fall and winter months and lowest during the summer
months. Prices for shell eggs fluctuate in response to seasonal demand factors and a natural increase in egg production during
the spring and early summer. Historically, shell egg prices tend to increase with the start of the school year and tend to be
highest prior to holiday periods, particularly Thanksgiving, Christmas and Easter. Consequently, and all other things being
equal, we would expect to experience lower selling prices, sales volumes and net income (and may incur net losses) in our first
and fourth fiscal quarters ending in August/September and May/June, respectively. Because of the seasonal and quarterly
fluctuations, comparisons of our sales and operating results between different quarters within a single fiscal year are not
necessarily meaningful comparisons.
We routinely fill our storage bins during harvest season when prices for feed ingredients are generally lower. To ensure
continued availability of feed ingredients, we may enter into contracts for future purchases of corn and soybean meal, and as
part of these contracts, we may lock-in the basis portion of our grain purchases several months in advance. Basis is the
difference between the local cash price for grain and the applicable futures price. A basis contract is a common transaction in
the grain market that allows us to lock-in a basis level for a specific delivery period and wait to set the futures price at a later
date. Furthermore, due to the more limited supply for organic ingredients, we may commit to purchase organic ingredients in
advance to help ensure supply. Ordinarily, we do not enter into long-term contracts beyond a year to purchase corn and soybean
meal or hedge against increases in the prices of corn and soybean meal. Corn and soybean meal are commodities and are
subject to volatile price changes due to weather, various supply and demand factors, transportation and storage costs,
speculators, agricultural, energy and trade policies in the U.S. and internationally , and global instability that could disrupt the
supply chain.
An important competitive advantage for Cal-Maine Foods is our ability to meet our customers’ evolving needs with a favorable
product mix of conventional and specialty eggs, including cage-free, organic and other specialty offerings, as well as egg
products. We have also enhanced our efforts to provide free-range and pasture-raised eggs that meet consumers’ evolving
choice preferences. While a small part of our current business, the free-range and pasture-raised eggs we produce and sell
represent attractive offerings to a subset of consumers, and therefore our customers, and help us continue to serve as the trusted
provider of quality food choices.
CAGE-FREE EGGS
Ten states have passed legislation or regulations mandating minimum space or cage-free requirements for egg production or
mandated the sale of only cage-free eggs and egg products in their states, with implementation of these laws ranging from
January 2022 to January 2026. These states represent approximately 27% of the U.S. total population according to the 2020
U.S. Census. California, Massachusetts, Colorado, Oregon, Washington, and Nevada, which collectively represent
approximately 20% of the total estimated U.S. population, have cage-free legislation currently in effect . Although we do not
sell the majority of our eggs in these ten states, these state laws have impacted egg production practices nationally.
A significant number of our customers have announced goals to either exclusively offer cage-free eggs or significantly increase
the volume of cage-free egg sales in the future, subject in most cases to availability of supply, affordability and consumer
demand, among other contingencies. Our customers typically do not commit to long-term purchases of specific quantities or
types of eggs with us, and as a result, it is difficult to accurately predict customer requirements for cage-free eggs. We are
focused on adjusting our cage-free production capacity with a goal of meeting the future needs of our customers in light of
changing state requirements and our customer’s goals. As always, we strive to offer a product mix that aligns with current and
anticipated customer purchase decisions. We are engaging with our customers to help them meet their announced goals and
needs. We have invested significant capital in recent years to acquire and construct cage-free facilities, and we expect our focus
for future expansion will continue to include cage-free facilities. Our volume of cage-free egg sales has continued to increase
and account for a larger share of our product mix. Cage-free egg revenue represented approximately 27.9% of our total net shell
egg revenue for the third quarter of fiscal year 2024. At the same time, we understand the importance of our continued ability to
provide conventional eggs in order to provide our customers with a variety of egg choices and to address hunger in our
communities.
For additional information, see the 2023 Annual Report, Part I Item 1, “Business – Specialty Eggs,” “Business – Growth
Strategy” and “Business – Government Regulation,” and the first risk factor in Part I Item 1A, “Risk Factors” under the sub-
heading “Legal and Regulatory Risk Factors.”
ACQUISITIONS
During the second quarter of fiscal 2024, we acquired the assets of Fassio Egg Farms, Inc. (“Fassio”) related to its commercial
shell egg production and processing business. The assets acquired included commercial shell egg production and processing
facilities with a capacity at the time of acquisition of approximately 1.2 million laying hens, primarily cage-free, a feed mill, pullets, a fertilizer production and composting operation and land located in Erda, Utah, outside Salt Lake City. See further discussion in
Note 2 – Acquisition
of the Notes to Condensed Consolidated Financial Statements included in this Quarterly
Report.
Following the end of the third quarter, we announced that we completed the acquisition from Tyson Foods, Inc. of a recently
closed broiler processing plant, hatchery and feed mill located in Dexter, Missouri. We plan to repurpose the assets for use in
egg and egg products production.
HPAI
Since the HPAI outbreaks in 2015, there were no reported significant outbreaks of HPAI in the commercial table egg layer
flocks until the February – December 2022 time period. During this time approximately 43 million commercial layers and 1.0
million pullets were depopulated resulting in significant pressure on the supply of eggs. Thereafter, there were no HPAI cases
affecting commercial layers until November 2023. From November 2023 until the last reported case in commercial layer hens
in January 2024, approximately 15.7 million commercial laying hens and pullets were depopulated.
During the third quarter of fiscal 2024, Cal-Maine Foods experienced an HPAI outbreak within its facilities in Kansas, resulting
in depopulation of approximately 1.5 million laying hens and 240,000 pullets, or approximately 3.3% of our total flock at the
time. Following the end of the third quarter, on April 1, 2024, one of the Company’s facilities located in Parmer County, Texas,
tested positive for HPAI, resulting in depopulation of approximately 1.6 million laying hens and 337,000 pullets, or
approximately 3.6% of the Company’s total flock as of March 2, 2024. Production at the facility has temporarily ceased as the
Company follows the protocols prescribed by the USDA. Cal-Maine Foods is working to secure production from other facilities
to minimize disruption to its customers.
The Company remains dedicated to robust biosecurity programs across its locations; however, no farm is immune from HPAI.
HPAI is still present in the wild bird population and the extent of possible future outbreaks, with heightened risk during the
migration seasons, cannot be predicted. According to the U.S. Centers for Disease Control and Prevention, the human health
risk to the U.S. public from HPAI viruses is considered to be low. Also, according to the USDA, HPAI cannot be transmitted
through safely handled and properly cooked eggs. There is no known risk related to HPAI associated with eggs that are
currently in the market and no eggs have been recalled. For additional information, see the 2023 Annual Report, Part II Item 7
“Management’s Discussion and Analysis of Financial Condition and Results of Operations – HPAI.”
EXECUTIVE OVERVIEW
For the third quarter and first three quarters of fiscal 2024, we recorded a gross profit of $218.6 million and $355.1 million,
respectively, compared to $463.0 million and $998.4 million, respectively, for the same periods of fiscal 2023, with the
decreases due primarily to lower conventional shell egg prices. The decrease in gross profit was partially offset by lower feed
ingredient prices in the third quarter and first three quarters of fiscal 2024 compared to the same periods of fiscal 2023.
Our net average selling price per dozen for the third quarter of fiscal 2024 was $2.247 compared to $3.298 in the prior-year
period. Conventional egg prices per dozen were $2.152 compared to $3.678 for the prior-year period, and specialty egg prices
per dozen were $2.415 compared to $2.616 for the prior-year period. Egg prices in the third quarter of fiscal 2023 were elevated
compared to historical averages prior to fiscal 2023 primarily due to the resurgence of HPAI outbreaks and other market factors
in November 2023 through January 2024, as described above and herein. Although egg prices in the third quarter of 2024 were
lower than in the prior-year period, they were elevated above historical averages due to the resurgence of HPAI in November
2023. According to the USDA, the five-year average of the monthly average size of the layer hen flock from December through
February (which most closely aligns with our third fiscal quarter) through 2023 is 330.2 million hens. The monthly average
layer hen flock from December 2023 through February 2024 was 312.2 million, which is 18.0 million or 5.5% less than the
five-year average. During both the third quarters of 2023 and 2024, supply constraints as well as seasonal demand during the
holidays put upward pressure on the price of shell eggs.
Our net average selling price per dozen for the first three quarters of fiscal 2024 was $1.866 compared to $2.771 in the prior-
year period. Conventional egg prices per dozen were $1.624 compared to $2.984 for the prior-year period, and specialty egg
prices per dozen were $2.328 compared to $2.369 for the prior-year period. The daily average price for the Urner Barry
southeast large index for the third quarter of fiscal 2024 and first three quarters of fiscal 2024 decreased 35.2% and 43.7%,
respectively, from the comparable periods in the prior year. For information about historical shell egg prices, see Part I Item I of
our 2023 Annual Report.
In the third quarter of 2024, we achieved record quarterly sales volume of total dozens sold and specialty dozens sold. Our total
dozens sold increased 3.2% to 300.8 million dozen shell eggs for the third quarter of fiscal 2024 compared to 291.4 million
dozen for the same period of fiscal 2023. For the year-to-date period, total dozens sold increased 1.3% from 850.8 million dozen to 862.0 million dozen. For the third quarter of fiscal 2024, conventional dozens sold increased 2.6% and specialty dozens sold increased 4.4% as compared to the same quarter in fiscal 2023. Demand for specialty eggs increased in the third quarter of fiscal 2024 compared to the same prior year period due primarily to cage-free requirements becoming effective for
Nevada, Oregon and Washington on January 1, 2024. For the year-to-date period, conventional dozens sold increased 2.0% and
specialty dozens sold remained consistent compared to the prior year period.
Our farm production costs per dozen produced for the third quarter and first three quarters of fiscal 2024 decreased 10.5%, or
$0.11, and 6.6%, or $0.07, respectively, compared to the prior year periods, primarily due to lower feed costs. Feed costs per
dozen produced decreased 19.9%, or $0.14, compared to the third quarter of fiscal 2023 and 16.7%, or $0.11, for the first three
quarters of fiscal 2023, primarily due to lower feed ingredient prices. For information about historical corn and soybean meal
prices, see Part I Item I of our 2023 Annual Report.
RESULTS OF OPERATIONS
The following table sets forth, for the periods indicated, certain items from our Condensed Consolidated Statements of Income
expressed as a percentage of net sales.
Thirteen Weeks Ended
Thirty-nine Weeks Ended
March 2, 2024
February 25, 2023
March 2, 2024
February 25, 2023
Net sales
100.0
100.0
100.0
100.0
Cost of sales
68.9
53.6
78.9
59.4
Gross profit
31.1
46.4
21.1
40.6
Selling, general and administrative
9.3
5.9
11.6
6.9
Gain on involuntary conversions
(1.4)
(0.3)
(0.6)
(0.1)
Operating income
23.2
40.8
10.1
33.8
Total other income, net
3.2
1.7
2.2
0.9
Income before income taxes
26.4
42.5
12.3
34.7
Income tax expense
5.5
10.2
2.6
8.4
Net income
20.9
32.3
9.7
26.3
Less: Loss attributable to noncontrolling
interest
(0.1)
Net income attributable to Cal-Maine
Foods, Inc.
20.9
32.3
9.8
26.3
NET SALES
Total net sales for the third quarter of fiscal 2024 were $703.1 million compared to $997.5 million for the same period of fiscal
Net shell egg sales represented 96. 9% and 96.7% of total net sales for the third quarters of fiscal 2024 and 2023, respectively.
Shell egg sales classified as “Other” represent sales of miscellaneous byproducts and resale products included with our shell
egg operations.
Total net sales for the thirty-nine weeks ended March 2, 2024 were $1.7 billion, compared to $2.5 billion for the comparable
period of fiscal 2023.
Net shell egg sales represented 96.2% and 96.4% of total net sales for the thirty-nine weeks ended March 2, 2024 and February
25, 2023, respectively.
The table below presents an analysis of our conventional and specialty shell egg sales (in thousands, except percentage data):
Thirteen Weeks Ended
Thirty-nine Weeks Ended
March 2, 2024
February 25, 2023
March 2, 2024
February 25, 2023
Total net sales
703,076
997,493
1,685,654
2,457,537
Conventional
413,619
60.7
689,022
71.4
919,498
56.7
1,656,528
69.9
Specialty
262,293
38.5
272,205
28.2
688,879
42.5
700,803
29.6
Egg sales, net
675,912
99.2
961,227
99.6
1,608,377
99.2
2,357,331
99.5
Other
5,405
0.8
3,684
0.4
13,283
0.8
11,932
0.5
Net shell egg sales
681,317
100.0
964,911
100.0
1,621,660
100.0
2,369,263
100.0
Net shell egg sales as a
percent of total net sales
96.9
96.7
96.2
96.4
Dozens sold:
Conventional
192,182
63.9
187,357
64.3
566,174
65.7
555,045
65.2
Specialty
108,597
36.1
104,059
35.7
295,904
34.3
295,774
34.8
Total dozens sold
300,779
100.0
291,416
100.0
862,078
100.0
850,819
100.0
Net average selling price
per dozen:
Conventional
2.152
3.678
1.624
2.984
Specialty
2.415
2.616
2.328
2.369
All shell eggs
2.247
3.298
1.866
2.771
Egg products sales:
Egg products net sales
21,759
32,582
63,994
88,274
Pounds sold
18,745
16,796
55,096
49,000
Net average selling price
per pound
1.161
1.940
1.161
1.802
Shell egg net sales
Third Quarter – Fiscal 2024 vs. Fiscal 2023
In the third quarter of fiscal 2024, conventional egg sales decreased $275.4 million, or 40.0%, compared to the third
quarter of fiscal 2023, primarily due to a 41.5% decrease in the prices for conventional eggs, which resulted in a
$293.3 million decrease in net sales, partially offset by a 2.6% increase in the volume of conventional eggs sold, which
resulted in a $17.7 million increase in net sales.
Conventional egg prices reached record highs in third quarter fiscal 2023 due to HPAI outbreaks experienced
throughout calendar year 2022 as well seasonal demand during the winter holidays. Prices were lower in the first half
of fiscal 2024 compared to the same period of fiscal 2023 as the U.S. egg supply started to recover from outbreaks of
HPAI. There has been a resurgence of HPAI starting in November 2023, and continuing through the third quarter of
fiscal 2024, which increased prices due to supply constraints. However, prices remained lower than the third quarter of
fiscal 2023.
Specialty egg sales decreased $9.9 million, or 3.6%, in the third quarter of fiscal 2024 compared to the third quarter of
fiscal 2023, primarily due to a 7.7% decrease in the prices for specialty eggs, which resulted in a $11.9 million
decrease in net sales.
Our total dozens sold and specialty dozens sold during the third quarter of fiscal 2024 were records for our Company.
Demand for specialty eggs increased in the third quarter of fiscal 2024 compared to the same prior year period,
primarily due to cage-free requirements becoming effective for Nevada, Oregon and Washington effective January 1,
Thirty-nine weeks – Fiscal 2024 vs. Fiscal 2023
For the thirty-nine weeks ended March 2, 2024, conventional egg sales decreased $737.0 million, or 44.5%, compared
to the same period of fiscal 2023, primarily due to the decrease in the prices for conventional shell eggs. Changes in
prices resulted in a $770.0 million decrease in net sales, partially offset by a 2.0% increase in the volume of
conventional eggs sold, which resulted in a $33.2 million increase in net sales.
During the first three quarters of fiscal 2024, the U.S. egg supply was recovering from the earlier HPAI outbreaks,
leading to lower egg prices than the prior year period, although as noted above there was a resurgence in HPAI starting
in November 2023.
Egg products net sales
Third Quarter – Fiscal 2024 vs. Fiscal 2023
Egg products net sales decreased $10.8 million, or 33.2%, for the third quarter of fiscal 2024 compared to the same
period of fiscal 2023, primarily due to a 40.2% selling price decrease, which had a $14.6 million negative impact on
net sales.
Our egg products net average selling price decreased in the third quarter of fiscal 2024, compared to the third quarter
of fiscal 2023 as the supply of shell eggs used to produce egg products increased.
Thirty-nine weeks – Fiscal 2024 vs. Fiscal 2023
Egg products net sales decreased $24.3 million, or 27.5%, primarily due to a 35.6% selling price decrease compared to
the first thirty-nine weeks of fiscal 2023, which had a $35.3 million negative impact on net sales.
Our egg products net average selling price decreased in the first three quarters of fiscal 2024, compared to the prior
year period as the supply of shell eggs used to produce egg products increased.
COST OF SALES
Costs of sales for the third quarter of fiscal 2024 were $484.5 million compared to $534.5 million for the same period of fiscal
2023. Costs of sales for the year-to-date period were $1.3 billion compared to $1.5 billion for the prior year period.
The following table presents the key variables affecting our cost of sales (in thousands, except cost per dozen data):
Thirteen Weeks Ended
Thirty-nine Weeks Ended
March 2, 2024
February 25,
2023
Change
March 2, 2024
February 25,
2023
Change
Cost of Sales:
Farm production
248,650
280,384
(11.3)
760,525
823,043
(7.6)
Processing, packaging, and
warehouse
86,423
87,037
(0.7)
253,096
252,093
0.4
Egg purchases and other
(including change in
inventory)
127,925
135,003
(5.2)
260,375
301,274
(13.6)
Total shell eggs
462,998
502,424
(7.8)
1,273,996
1,376,410
(7.4)
Egg products
21,506
32,043
(32.9)
56,523
82,762
(31.7)
Total
484,504
534,467
(9.3)
1,330,519
1,459,172
(8.8)
Farm production costs (per
dozen produced)
Feed
0.544
0.679
(19.9)
0.564
0.677
(16.7)
Other
0.421
0.399
5.5
0.431
0.388
11.1
Total
0.965
1.078
(10.5)
0.995
1.065
(6.6)
Outside egg purchases
(average cost per dozen)
2.44
3.72
(34.4)
2.09
3.20
(34.7)
Dozens produced
259,527
263,174
(1.4)
774,984
782,186
(0.9)
Percent produced to sold
86.3%
90.3%
(4.4)
89.9%
91.9%
(2.2)
Farm Production
Third Quarter – Fiscal 2024 vs. Fiscal 2023
Feed costs per dozen produced decreased 19.9% in the third quarter of fiscal 2024 compared to the third quarter of
fiscal 2023. This decrease was primarily due to lower prices for corn and soybean meal, our primary feed ingredients.
The decrease in feed cost per dozen resulted in a decrease in cost of sales of $35.0 million for the third quarter of fiscal
2024 compared to the prior period quarter.
For the third quarter of fiscal 2024, the average Chicago Board of Trade (“CBOT”) daily market price was $4.51 per
bushel for corn and $370 per ton of soybean meal, representing decreases of 32.4% and 21.8%, respectively, as
compared to the average CBOT daily market prices for the third quarter of fiscal 2023. Basis levels for corn and
soybean meal were lower in our areas of operations compared to our prior year third fiscal quarter.
Other farm production costs increased primarily due to higher flock amortization and, to a lesser extent, increased
facility costs. Flock amortization increased primarily due to the increased capitalized value of our flocks. This is
primarily due to the higher feed costs in earlier periods incurred during the growing phase of the flocks.
Facility costs increased due to higher repairs and maintenance costs in the third quarter of fiscal 2024 compared to the
third quarter of fiscal 2023.
Thirty-nine weeks – Fiscal 2024 vs. Fiscal 2023
Feed costs per dozen produced decreased 16.7% in the thirty-nine weeks ended March 2, 2024 compared to the same
period of fiscal 2023, primarily due to lower feed ingredient prices. The decrease in feed cost per dozen resulted in a
decrease in cost of sales of $87.6 million compared to the prior year period .
For the year-to-date period, the average CBOT daily market price was $4.87 per bushel for corn and $403 per ton for
soybean meal, representing decreases of 27.3% and 10.5%, respectively, compared to the average CBOT daily market
prices for the comparable period in the prior year. In addition, basis levels for corn and soybean meal were lower for
the thirty-nine weeks ended March 2, 2024 compared to the same period of fiscal 2023.
Other farm production costs increased due primarily to higher flock amortization, for the reasons described above, as
well as increased facility costs.
Facility costs increased due primarily to increased contract labor in response to labor shortages, as well as higher
repairs and maintenance costs for the thirty-nine weeks ended March 2, 2024 compared to the same period of fiscal
Current indications for corn project an overall better stocks-to-use ratio implying potentially lower prices in the near term;
however, as long as outside factors remain uncertain (including weather patterns and global supply chain disruptions), volatility
could remain. Soybean meal supply has remained tight relative to demand in the first three quarters of fiscal 2024.
Processing, packaging, and warehouse
Third Quarter – Fiscal 2024 vs. Fiscal 2023
Processing, packaging, and warehouse costs decreased 0.7% compared to the third quarter of fiscal 2023 as we
processed fewer dozens primarily due to the HPAI outbreak at our Kansas facilities. The decrease was slightly offset
by inflationary costs in the third quarter of fiscal 2024 compared to the third quarter of fiscal 2023.
Thirty-nine weeks – Fiscal 2024 vs. Fiscal 2023
Processing, packaging, and warehouse costs increased 0.4% compared to the first three quarters of fiscal 2023,
primarily due to an increase in costs due to inflationary pressure, partially offset by a reduction in the volume of
processed dozens.
Egg purchases and other (including change in inventory)
Third Quarter – Fiscal 2024 vs. Fiscal 2023
Costs in this category decreased primarily due to lower shell egg prices as the average cost per dozen of outside egg
purchases decreased 34.4% compared to third quarter of fiscal 2023, partially offset by an increase of 36.4% in dozens
purchased due to the loss of production caused by the HPAI outbreak at our Kansas facilities as well as an increase in
sales volume.
Thirty-nine weeks – Fiscal 2024 vs. Fiscal 2023
Costs in this category decreased primarily due to lower shell egg prices as the average cost per dozen of outside egg
purchases decreased 34.7% compared to fiscal 2023, partially offset by an increase of 21.9% in dozens purchased for
the reasons discussed above.
GROSS PROFIT
Gross profit for the third quarter of fiscal 2024 was $218.6 million compared to $463.0 million for the same period of fiscal
2023. Gross profit for the thirty-nine weeks ended March 2, 2024 was $355.1 million compared to $998.4 million for the same
period of 2023. The decrease for both periods was primarily due to lower conventional egg prices, partially offset by lower feed
ingredient prices.
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES
Selling, general, and administrative (“SGA”) expenses include costs of marketing, distribution, accounting and corporate
overhead. The following table presents an analysis of our SGA expenses (in thousands):
Thirteen Weeks Ended
March 2, 2024
February 25, 2023
$ Change
% Change
Specialty egg expense
20,173
15,689
4,484
28.6
Delivery expense
18,832
19,453
(621)
(3.2)
Payroll, taxes and benefits
13,134
14,325
(1,191)
(8.3)
Stock compensation expense
1,111
1,059
52
4.9
Other expenses
12,770
7,963
4,807
60.4
Total
66,020
58,489
7,531
12.9
Third Quarter – Fiscal 2024 vs. Fiscal 2023
Specialty egg expense
During the second part of fiscal year 2023, the higher prices for conventional eggs and the comparatively lower prices
for specialty eggs diminished the need to promote specialty eggs. During the third quarter of fiscal year 2024, we
significantly increased promotional programs, resulting in higher advertising fees. This was partially offset by a
reduction in franchise fees paid to Eggland’s Best, Inc.
Delivery expense
The decreased delivery expense is primarily due to a decrease in fuel and contract trucking expenses in the third
quarter of fiscal 2024 compared to the third quarter of fiscal 2023.
Payroll, taxes and benefits expense
The decrease in payroll, taxes and benefits expense is due to a decrease in accrued bonuses compared to the third
quarter of fiscal 2023 as well as a reduction in employee insurance expenses compared to the third quarter of fiscal
Other expense
The increase in other expense is primarily due to increased legal costs incurred compared to the third quarter of fiscal
Thirty-nine Weeks Ended
March 2, 2024
February 25, 2023
$ Change
% Change
Specialty egg expense
48,102
43,429
4,673
10.8
Delivery expense
54,229
57,544
(3,315)
(5.8)
Payroll, taxes and benefits
36,276
39,139
(2,863)
(7.3)
Stock compensation expense
3,212
3,071
141
4.6
Litigation loss contingency accrual
19,648
19,648
N.M.
Other expenses
33,377
26,865
6,512
24.2
Total
194,844
170,048
24,796
14.6
N.M. - Not Meaningful
Thirty-nine weeks – Fiscal 2024 vs. Fiscal 2023
Specialty egg expense
Specialty egg expense increased by 10.8%, as advertising expense increased in fiscal 2024 as discussed above and was
partially offset by the reduction in franchise fees paid to Eggland’s Best, Inc.
Delivery expense
The decreased delivery expense is primarily due to a decrease in fuel and contract trucking expenses in fiscal 2024.
Payroll, taxes and benefits expense
The decrease in payroll, taxes and benefits expense is primarily due to a decrease in accrued bonuses in the first three
quarters of fiscal 2024 compared to the prior year period.
Litigation loss contingency accrual
The litigation loss contingency accrual of $19.6 million relates to a jury decision returned on December 1, 2023 in
pending anti-trust litigation. See further discussion in
Note 10 - Commitments and Contingencies
of the Notes to
Condensed Consolidated Financial Statements included in this Quarterly Report.
Other expenses
The increase in other expense is primarily due to increased legal costs incurred in the year-to-date period.
GAIN ON INVOLUNTARY CONVERSIONS
For the third quarter of fiscal 2024 and 2023, we recorded a gain of $9.9 million and $3.2 million, respectively, due to
recoveries under indemnity and insurance programs that exceeded the amortized book value of the covered assets and our direct
costs.
OPERATING INCOME (LOSS)
For the third quarter of fiscal 2024, we recorded operating income of $162.8 million compared to operating income of $407.8
million for the same period of fiscal 2023.
For the thirty-nine weeks ended March 2, 2024, we recorded an operating income of $170.3 million compared to an operating
income of $831.5 million for the same period of fiscal 2023.
OTHER INCOME (EXPENSE)
Total other income (expense) consists of items not directly charged or related to operations, such as interest income and
expense, royalty income, equity income or loss of unconsolidated entities, and patronage income, among other items.
For the third quarter of fiscal 2024, we earned $7.8 million of interest income compared to $6.3 million for the same period of
fiscal 2023. The increase resulted from higher investment balances and interest rates. The Company recorded interest expense
of $247 thousand and $143 thousand for the third quarters ended March 2, 2024 and February 25, 2023, respectively.
For the thirty-nine weeks ended March 2, 2024, we earned $22.4 million of interest income compared to $9.4 million for the
same period of fiscal 2023. The increase resulted from significantly higher investment balances and higher interest rates. The
Company recorded interest expense of $523 thousand and $433 thousand for the thirty-nine weeks ended March 2, 2024 and
February 25, 2023, respectively.
INCOME TAXES
For the third quarter of fiscal 2024, pre-tax income was $185.2 million compared to $424.9 million for the same period of fiscal
2023. We recorded income tax expense of $38.8 million for the third quarter of fiscal 2024, which reflects an effective tax rate
of 21.0%. This includes the discrete tax benefit of $6.4 million associated with the fiscal 2023 provision-to-return adjustments.
Excluding the discrete tax benefit, income tax expense was $45.2 million for the third quarter of fiscal 2024 with an adjusted
effective tax rate of 24.4%. Income tax expense was $102.1 million for the comparable period of fiscal 2023, which reflects an
effective tax rate of 24.0%.
For the thirty-nine weeks ended March 2, 2024, pre-tax income was $208.0 million compared to $852.6 million for the same
period of fiscal 2023. We recorded income tax expense of $44. 7 million, which reflects an effective tax rate of 21.5%. This
includes the discrete tax benefit of $6.4 million associated with the fiscal 2023 provision-to-return adjustments. Excluding the
discrete tax benefit, income tax expense was $51.0 million with an adjusted effective tax rate of 24.5%. We recorded income
tax expense of $206.4 million in the prior year period, which reflects an effective tax rate of 24.2%.
Our effective tax rate differs from the federal statutory income tax rate due to state income taxes, certain federal tax credits and
certain items included in income for financial reporting purposes that are not included in taxable income for income tax
purposes, including tax exempt interest income, certain nondeductible expenses and net income or loss attributable to our
noncontrolling interest.
NET INCOME ATTRIBUTABLE TO CAL-MAINE FOODS, INC.
Net income attributable to Cal-Maine Foods, Inc. for the third quarter ended March 2, 2024, was $146.7 million, or $3.01 per
basic and $3.00 per diluted common share, compared to net income attributable to Cal-Maine Foods, Inc. of $323.2 million, or
$6.64 per basic and $6.62 per diluted common share for the same period of fiscal 2023.
Net income attributable to Cal-Maine Foods, Inc. for the thirty-nine weeks ended March 2, 2024, was $164.6 million, or $3.38
per basic and $3.37 per diluted common share, compared to net income attributable to Cal-Maine Foods, Inc. of $647.1 million
or $13.31 per basic and $13.25 per diluted common share, for the same period of fiscal 2023.
LIQUIDITY AND CAPITAL RESOURCES
Working Capital and Current Ratio
Our working capital at March 2, 2024 was $1.0 billion, compared to $942.2 million at June 3, 2023. The calculation of working
capital is defined as current assets less current liabilities. Our current ratio was 5.7 at March 2, 2024, compared with 6.2 at June
3, 2023. The current ratio is calculated by dividing current assets by current liabilities.
Cash Flows from Operating Activities
For the thirty-nine weeks ended March 2, 2024, $237.6 million in net cash was provided by operating activities, compared to
$706.5 million provided by operating activities for the comparable period in fiscal 2023. The decrease in cash flow from
operating activities resulted primarily from lower selling prices for conventional eggs compared to the prior-year period.
Cash Flows from Investing Activities
For the thirty-nine weeks ended March 2, 2024, $118.4 million was used in investing activities, primarily due to the purchases
of investment securities, the acquisition of assets of Fassio Egg Farms, Inc., and purchases of property, plant and equipment.
This compares to $397.6 million used in investing activities in the same period of fiscal 2023, primarily due to purchases of
investment securities and purchases of property, plant and equipment. Sales and maturities of investment securities were $273.9
million in first three quarters of fiscal 2024, compared to $132.7 million in the first three quarters fiscal 2023. The increase in
sales and maturities of investment securities is primarily due to the maturities of short-term investments during the period.
Purchases of property, plant and equipment were $96.0 million and $86.2 million in the first three quarters of fiscal 2024 and
2023, respectively, primarily reflecting progress on our construction projects.
Cash Flows from Financing Activities
We paid dividends of $43.0 million for the thirty-nine weeks ended March 2, 2024 compared to $144.6 million in the same
prior-year period.
As of March 2, 2024, cash increased $74.3 million since June 3, 2023, compared to an increase of $162.5 million during the
same period of fiscal 2023.
Credit Facility
We had no long-term debt outstanding at March 2, 2024 or June 3, 2023. On November 15, 2021, we entered into a credit
agreement that provides for a senior secured revolving credit facility (the “Credit Facility”), in an initial aggregate principal
amount of up to $250 million with a five-year term. As of March 2, 2024, no amounts were borrowed under the Credit Facility.
We have $4.3 million in outstanding standby letters of credit issued under our Credit Facility for the benefit of certain insurance
companies. Refer to Part II Item 8, Notes to Consolidated Financial Statements and Supplementary Data, Note 10 - Credit
Facility included in our 2023 Annual Report for further information regarding our long-term debt.
Dividends
In accordance with our variable dividend policy, we will pay a cash dividend totaling approximately $48.9 million, or
approximately $0.997 per share to holders of our common and Class A common stock with respect to our third fiscal quarter of
2024. The amount paid per share will vary based on the number of outstanding shares on the record date. The dividend is
payable on May 16, 2024 to holders of record on May 1, 2024.
Material Cash Requirements
We continue to monitor the increasing demand for cage-free eggs and to engage with our customers in efforts to achieve a
smooth transition toward their announced timelines for cage-free egg sales. The following table presents material construction
projects approved as of March 2, 2024 (in thousands):
Project(s) Type
Projected
Completion
Projected Cost
Spent as of March 2,
2024
Remaining
Projected Cost
Cage-Free Layer & Pullet Houses
Fiscal 2025
72,915
49,379
23,536
Feed Mill
Fiscal 2025
10,479
3,165
7,314
Dexter, MO Renovations
Fiscal 2025
11,000
11,000
Cage-Free Layer & Pullet Houses
Fiscal 2026
82,298
66,823
15,475
Cage-Free Layer & Pullet Houses
Fiscal 2027
56,923
32,991
23,932
233,615
152,358
81,257
We believe our current cash balances, investments, cash flows from operations, and Credit Facility will be sufficient to fund our
current cash needs for at least the next 12 months.
IMPACT OF RECENTLY ISSUED/ADOPTED ACCOUNTING STANDARDS
For information on changes in accounting principles and new accounting policies, see
Note 1 - Summary of Significant
Accounting Policies
of the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report.
CRITICAL ACCOUNTING ESTIMATES
Critical accounting estimates are those estimates made in accordance with U.S. generally accepted accounting principles that
involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our
financial condition or results of operations. There have been no changes to our critical accounting estimates identified in our
2023 Annual Report.
Market risk
As filed, 253 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes in our exposure to market risk during the thirty-nine weeks ended March 2, 2024 from the
information provided in Part II Item 7A, Quantitative and Qualitative Disclosures About Market Risk in our 2023 Annual
Report.
Controls and procedures
As filed, 1,458 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
AND
PROCEDURES
Disclosure Controls and Procedures
Our disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed
by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time
periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include,
without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that
we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive
and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding
required disclosure. Based on an evaluation of our disclosure controls and procedures conducted by our Chief Executive Officer
and Chief Financial Officer, together with other financial officers, such officers concluded that our disclosure controls and
procedures were effective as of March 2, 2024 at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the quarter ended March 2, 2024 that
has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 194 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
FACTORS
There have been no material changes in the risk factors previously disclosed in the Company’s 2023 Annual Report, except as
reported herein in Part I Item 2 under the heading “HPAI.”
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-12-03 to 2024-03-02 | $703.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-06-04 to 2024-03-02 | $1.69bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-12-03 to 2024-03-02 | $484.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-06-04 to 2024-03-02 | $1.33bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-12-03 to 2024-03-02 | $218.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-06-04 to 2024-03-02 | $355.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-12-03 to 2024-03-02 | $66.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-06-04 to 2024-03-02 | $194.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-12-03 to 2024-03-02 | $162.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-06-04 to 2024-03-02 | $170.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-12-03 to 2024-03-02 | $38.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-06-04 to 2024-03-02 | $44.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-12-03 to 2024-03-02 | $146.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-06-04 to 2024-03-02 | $164.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-12-03 to 2024-03-02 | $3.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-06-04 to 2024-03-02 | $3.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-12-03 to 2024-03-02 | $3.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-06-04 to 2024-03-02 | $3.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-12-03 to 2024-03-02 | 48,884,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-06-04 to 2024-03-02 | 48,865,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-06-04 to 2024-03-02 | $237.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-06-04 to 2024-03-02 | $96.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2023-06-04 to 2024-03-02 | $43.0m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2024-03-02 | $367.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-02 | $1.22bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-02 | $2.13bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-02 | $215.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-02 | $412.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-02 | $1.72bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001562762-24-000077. Last ingested by Listed: Oct 24, 2026, 14:51 ET. Listed shows no prices and gives no investment advice.